rediff.com
e.g. Tata motors, Reliance MF, 500570
Sudarshan Pharma Industries Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate
Download announcement < Back
06 Mar 2025
We inform you that at the meeting of Board of Directors of the Company on 6th March, 2025 the Board has, on the recommendation of the Nomination and Remuneration Committee, with Consent of Mr. Manoj Lodha, appointed Mr. Manoj Lodha as an Executive Director and Chief Financial Officer of the Company w.e.f. 1st April, 2025.
View all announcements for Sudarshan Pharma Industries Ltd Source: BSE India